Description  Claims  Drawing  Cited references 

US5547991A   [0008]  [0024] 
US2011306674A   [0008] 

European Journal of Pharmacology   [0006] 
Neuroscience Letters   [0006] 
Experimental Neurology   [0006] 
Neuropharmacology   [0006] 
European Journal of Pharmacology   [0006] 
Enzyme-Activated Antagonists of the Strychnine-Insensitive Glycine/NMDA Receptor   [0024] 
Clinical Aspects and Management of Levodopa-Induces Dyskinesia   [0029] 
Remington's Pharmaceutical Sciences   [0031] 
Stress-Induced Changes of Hippocampal NMDA Receptors: Modulation by Duloxetine Treatment   [0048] 
Glycine antagonist: Regulation of the NMDA receptor channel complex by the strychnine-insensitive glycine site   [0050] 
Competitive Gly/NMDA receptor antagonists   [0050] 
Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid   [0050] 
7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex   [0050] 
Schwarcz R. Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo   [0050] 
The glycine site on the NMDA receptor: Structure-activity relationships and therapeutic potential   [0050] 
Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis   [0050] 
Novel systemically active antagonists of the glycine site of the N-methyl-D-aspartate receptor: electrophysiological, biochemical and behavioral characterization   [0050] 
Indole-2-carboxylates, novel antagonists of the N-methyl-D-aspartate (NMDA)-associated glycine recognition sites: in vivo characterization   [0050] 
Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy   [0050] 
L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat   [0050] 
Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus   [0050]